Drug repurposing screen identifies novel small molecule compounds with potent antifibrotic properties von Belanger, C, Foucart, C, Negro, E, Dubernet, M, Hum, D.W, Staels, B, Walczak, R

Volltext

The Identification of Novel Small Molecule Compounds with Potent Anti-Fibrotic Properties by Phenotypic Screening of Primary Human Stellate Cells von Belanger, C, Dubernet, M, Negro, E, Darteil, R, Hum, D.W, Staels, B, Walczak, R

Volltext

RORgt Inhibition in the Liver Prevents Hepatic Fibrosis Progression, a Proof of Concept Study with a Potent, First in Class, Hepatocentric RORgt Inverse Agonist von Majd, Z, Delhomel, J.-F, Delataille, P, Delbaere, I, Le Parquier, M, Hum, D.W, Staels, B, Walczak, R

Volltext

SAT-345 - Drug repurposing screen identifies novel small molecule compounds with potent antifibrotic properties von Belanger, C., Foucart, C., Negro, E., Dubernet, M., Hum, D.W., Staels, B., Walczak, R.

Volltext

SAT-418 - The Identification of Novel Small Molecule Compounds with Potent Anti-Fibrotic Properties by Phenotypic Screening of Primary Human Stellate Cells von Belanger, C., Dubernet, M., Negro, E., Darteil, R., Hum, D.W., Staels, B., Walczak, R.

Volltext

O78 Le GFT505, premier co-agoniste PPAR α/δ, a une double action favorable sur les paramètres lipidiques et glucidiques chez les sujets pré-diabétiques von Cariou, B, Hanf, R, Bruckert, E, Darteil, R, Hum, D.W, Staels, B

Volltext

FRI-253 - RORgt Inhibition in the Liver Prevents Hepatic Fibrosis Progression, a Proof of Concept Study with a Potent, First in Class, Hepatocentric RORgt Inverse Agonist von Majd, Z., Delhomel, J.-F., Delataille, P., Delbaere, I., Le Parquier, M., Hum, D.W., Staels, B., Walczak, R.

Volltext

Levels of plasma C19 steroids and 5 alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals von Guillemette, C, Hum, D. W, Belanger, A

Volltext

Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency von FARDELLA, C. E, HUM, D. W, RODRIGUEZ, H, ZHANG, G, BARRY, F. L, ILICKI, A, BLOCH, C. A, MILLER, W. L

Volltext

4.P.304 HDL (high density lipoprotein) and LDL (low density lipoprotein) receptors regulation in human adrenal cortex von Martin, G., Pilon, A., Albert, C., Vallè, M., Hum, D.W., Fruchart, J.C., Auwerx, J., Clavey, V., Staels, B.

Volltext

A pseudogene on the X chromosome for the human trifunctional enzyme MTHFD (methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate sy... von Italiano, C., John, S.W.M., Hum, D.W., MacKenzie, R.E., Rozen, R.

Volltext

2P-0529 A novel family of compounds with beneficial effects in mouse models of dyslipidemia and ischemic stroke von Millatt, L., Bertrand, K., Darteil, R., Verwaerde, P., Hum, D.W., Provost, N., Poulain, P., Majd, Z., Helleboid, S., Delhomel, J.-F., Bordet, R., Fruchart, J., Staels, B., Fruchart, J.-C.

Volltext

3P-0818 GFT14, a novel compound with hypolipidemic and neuroprotective properties von Millatt, L., Darteil, R., Bertrand, K., Verwaerde, P., Hum, D.W., Raspe, E., Poulain, P., Majd, Z., Helleboid, S., Bouey, E., Bordet, R., Fruchart, J., Staels, B., Fruchart, J.-C.

Volltext